Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.37 |
| ▸ | KDM4A | O75164 | 2/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.37 |
| ▸ | TET3 | O43151 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8495464 | 1.00 | OR51E2 (0.42) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL14661739 | 1.00 | OR51E2 (0.42) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL14661746 | 1.00 | OR51E2 (0.42) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL14661330 | 1.00 | OR51E2 (0.42) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL14662148 | 1.00 | OR51E2 (0.42) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL28482603 | 0.87 | OR51E2 (0.48) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL28492635 | 0.84 | OR51E2 (0.46) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL28482605 | 0.84 | OR51E2 (0.46) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL2231168 | 0.81 | GPR84 (0.48) | OR51E2GPR84FFAR1TP53SMN1; SMN2 | |
| SCHEMBL14661520 | 0.81 | GPR84 (0.48) | OR51E2GPR84FFAR1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009127009-A1 | CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | claimed |
| EP-0000560-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-HYDROXYCARBOXYLIC ACIDS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-02-03 | — | — | EP | claimed |
| US-4204044-A | SELECTIVE ASYMMETRIC, ENZYMATIC DEHYDROGENATIKN USING STREPTOMYCES, PSEUDOMONAS, BACILLUS OR CORYNEFORM MICROORGANISMS | HOFFMANN-LA ROCHE INC. (US) | 1980-05-20 | — | — | US | claimed |
| EP-0000560-A1 | Process for the preparation of optically active alpha-hydroxycarboxylic acids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-02-07 | — | — | EP | claimed |
| US-20240397944-A1 | METHODS FOR BIOFILM DISRUPTION | Lixa Limited (AU) | 2024-12-05 | — | — | US | disclosed |
| CN-115715547-B | Nematode extract and application thereof | 沈阳恩柽研究院有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-115715547-A | Nematode extract and application thereof | 沈阳恩柽研究院有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-113796390-B | Nematode extract and application thereof | 沈阳恩柽研究院有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-113796390-A | Nematode extract and application thereof | 沈阳恩柽研究院有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-105018384-B | One plant of acetic acid bacteria and its application in the apple vinegar that ferments | 江南大学 | 2018-07-06 | — | — | CN | disclosed |
| US-9688809-B2 | Method for purifying aliphatic polyester and aliphatic polyester purified with said method | MUSASHINO CHEMICAL LABORATORY, LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-20160083507-A1 | METHOD FOR PURIFYING ALIPHATIC POLYESTER AND ALIPHATIC POLYESTER PURIFIED WITH SAID METHOD | MUSASHINO CHEMICAL LABORATORY, LTD. (JP) | 2016-03-24 | — | — | US | disclosed |
| WO-2009031762-A2 | RECOMBINANT MICROORGANISM CAPABLE OF PRODUCING POLYLACTATE OR POLYLACTATE COPOLYMER FROM SUCROSE AND METHOD FOR PRODUCING POLYLACTATE OR POLYLACTATE COPOLYMER FROM SUCROSE USING THE SAME | LG CHEM, LTD. (KR) | 2009-03-12 | — | — | WO | disclosed |
| EP-1961739-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-27 | — | — | EP | disclosed |
| EP-1953595-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-7235251-B2 | Cosmetic or dermatological oil/water emulsions with reduced lipid content | BEIERSDORF AG (DE) | 2007-06-26 | — | — | US | disclosed |
| US-20030125386-A1 | Fatty acid nutritional supplement | BAYLOR UNIVERSITY MEDICAL CENTER | 2003-07-03 | — | — | US | disclosed |
| EP-0000560-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-HYDROXYCARBOXYLIC ACIDS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-02-03 | — | — | EP | disclosed |
| US-4204044-A | SELECTIVE ASYMMETRIC, ENZYMATIC DEHYDROGENATIKN USING STREPTOMYCES, PSEUDOMONAS, BACILLUS OR CORYNEFORM MICROORGANISMS | HOFFMANN-LA ROCHE INC. (US) | 1980-05-20 | — | — | US | disclosed |
| EP-0000560-A1 | Process for the preparation of optically active alpha-hydroxycarboxylic acids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240397944-A1 | METHODS FOR BIOFILM DISRUPTION | FGB, MMP8, HAO2 | OR51E2 3431/4885GPR84 3312/4885FFAR1 1313/4885 |
| US-20030125386-A1 | Fatty acid nutritional supplement | FASN, SLC27A1, SLC27A2 | OR51E2 4176/4885GPR84 460/4885FFAR1 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.